Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review

    Access Status
    Fulltext not available
    Authors
    Binju, M.
    Padilla, M.
    Singomat, T.
    Kaur, Pritinder
    Suryo Rahmanto, Y.
    Cohen, P.
    Yu, Yu
    Date
    2019
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Binju, M. and Padilla, M. and Singomat, T. and Kaur, P. and Suryo Rahmanto, Y. and Cohen, P. and Yu, Y. 2019. Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review. Biochimica et Biophysica Acta - General Subjects. 1863 (2): pp. 371-378.
    Source Title
    Biochimica et Biophysica Acta - General Subjects
    DOI
    10.1016/j.bbagen.2018.11.005
    ISSN
    0304-4165
    School
    School of Pharmacy and Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/72400
    Collection
    • Curtin Research Publications
    Abstract

    © 2018 Elsevier B.V. Background: Advanced epithelial ovarian cancer is one of the hardest human malignancies to treat. Standard treatment involves cytoreductive surgery and platinum-based chemotherapy, however, median progression-free survival for patients diagnosed with advanced stage disease (FIGO stages III and IV) is approximately 18 months. There has been little improvement in overall survival over the past decade and less than half of women with advanced stage disease will be living 5 years after diagnosis. A majority of patients initially have a favourable response to platinum-based chemotherapy, but most will eventually relapse and their disease will become platinum resistant. Scope of review: Here, we review our current understanding of mechanisms that promote recurrence and acquired resistance in epithelial ovarian cancer with particular focus on studies that describe differences observed between untreated primary tumors and recurrent tumors, post-first-line chemotherapy. Multiple molecular mechanisms contribute to recurrence in patients following initial treatment for advanced epithelial ovarian cancer including those involving the tumor microenvironment, tumor immune status, cancer stem cells, DNA repair/cell survival pathways and extracellular matrix. Major conclusions: Due to the adaptive nature of recurrent tumors, the major contributing and specific resistance pattern may largely depend on the nature of the primary tumor itself. General significance: Future work that aims to elucidate the complex pattern of acquired resistance will be useful for predicting chemotherapy response/recurrence following primary diagnosis and to develop novel treatment strategies to improve the survival of patients with advanced epithelial ovarian cancer, especially in tumors not harbouring homologous DNA recombination repair deficiencies.

    Related items

    Showing items related by title, author, creator and subject.

    • Pericytes promote malignant ovarian cancer progression in mice and predict poor prognosis in serous ovarian cancer patients
      Sinha, D.; Chong, L.; George, J.; Schlüter, H.; Mönchgesang, S.; Mills, S.; Li, J.; Parish, C.; Bowtell, D.; Kaur, Pritinder (2016)
      Purpose: The aim of this study was to investigate the role of pericytes in regulating malignant ovarian cancer progression. Experimental Design: The pericyte mRNA signature was used to interrogate ovarian cancer patient ...
    • Ovarian cancer stem cells and their role in drug resistance
      Pieterse, Z.; Amaya-Padilla, M.; Singomat, T.; Binju, M.; Madjid, B.; Yu, Y.; Kaur, Pritinder (2019)
      Ovarian cancer is typically diagnosed at advanced stages (III or IV), with metastasis ensuing at stage III. Complete remission is infrequent and is not achieved in almost half of the women diagnosed with ovarian cancer. ...
    • Mushroom Intake and Risk of Epithelial Ovarian Cancer in Southern Chinese Women
      Lee, Andy; Pasalich, Maria; Su, Dada; Tang, Li; Tran, D.; Binns, Colin (2013)
      OBJECTIVE: This study aimed to investigate the association between mushroom consumption and risk of epithelial ovarian cancer in southern Chinese women.METHODS: A hospital-based case-control study was undertaken in ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.